EGFR G796D mutation mediates resistance to osimertinib.
Zheng D, Hu M, Bai Y, Zhu X, Lu X, Wu C, Wang J, Liu L, Wang Z, Ni J, Yang Z, Xu J.
Zheng D, et al. Among authors: lu x.
Oncotarget. 2017 Jul 25;8(30):49671-49679. doi: 10.18632/oncotarget.17913.
Oncotarget. 2017.
PMID: 28572531
Free PMC article.